Stockscreener 앱 받기
0.1844
9.31%
0.0157
시간 외 거래:
.17
-0.0144
-7.81%
Glucotrack Inc 주식(GCTK)의 최신 뉴스
GlucoTrack Inc (GCTK) can make a big difference with a little luck - Sete News
Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial - Clinical Leader
GlucoTrack Releases Investor Presentation on April 29 - TipRanks
GlucoTrack Inc (NASDAQ:GCTK) stock crossing the finish line today - uspostnews.com
Can GlucoTrack Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Now Is The Time To Build A Position In GlucoTrack Inc (NASDAQ:GCTK) - Marketing Sentinel
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - ADVFN
It makes sense and dollars to buy GlucoTrack Inc (GCTK) stock - Sete News
Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews
GlucoTrack Joins EU Bionic Pancreas Initiative - TipRanks
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - The Manila Times
Major Breakthrough: Glucotrack Selected for EU's Revolutionary Bionic Pancreas Project - Stock Titan
Investing in GlucoTrack Inc (GCTK) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
GCTK stock plunges to 52-week low of $0.15 amid market turmoil By Investing.com - Investing.com South Africa
GCTK stock plunges to 52-week low of $0.15 amid market turmoil - Investing.com India
Glucotrack faces Nasdaq delisting over share price rule - Investing.com Australia
Glucotrack faces Nasdaq delisting over share price rule By Investing.com - Investing.com South Africa
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis By Investing.com - Investing.com South Africa
6 Alternatives to Apple’s Non-Invasive Glucose Monitoring You Can Try Now - The Mac Observer
GlucoTrack Partners with OneTwo Analytics for AI-Driven Insights - TipRanks
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis - Investing.com Australia
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - GlobeNewswire
Game-Changing Implantable Glucose Monitor Partners With AI Firm for 3-Year Clinical Study - Stock Titan
Glucotrack Reports Transformative Year with Clinical Advances - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
GlucoTrack Advances with Clinical Trials and Funding Boost - TipRanks
Glucotrack, Inc. SEC 10-K Report - TradingView
Glucotrack Transforms: First Human Trial Success Fuels Path to Revolutionary Multi-Year Glucose Monitor - Stock Titan
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week - MSN
GCTK Stock Plummets to 52-Week Low of $0.20 Amid Market Turbulence By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
GCTK Stock Plummets to 52-Week Low of $0.20 Amid Market Turbulence - Investing.com India
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
GlucoTrack Inc (NASDAQ: GCTK) Analysts Prediction On How Much It Could Rise - Stocks Register
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last - Asianet Newsable
Why Did GlucoTrack Plunge 15.72%? - AInvest
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack to Present at TechBio Showcase™ 2025 - The Globe and Mail
GCTK stock plunges to 52-week low, touches $0.31 By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
GCTK stock plunges to 52-week low, touches $0.31 - Investing.com
Pre-market Movers: IBO, ALUR, GCTK, TELA... - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
1.08%
자본화:
|
볼륨(24시간):